Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "Venus-Remedies"

50 News Found

Venus Remedies wins WHO GDP certification
Supply Chain | March 09, 2022

Venus Remedies wins WHO GDP certification

Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards


Venus Remedies join AMR alliance to combat global health threat
Biotech | February 07, 2022

Venus Remedies join AMR alliance to combat global health threat

The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry


Venus Remedies gets approval under the PLI scheme
News | December 11, 2021

Venus Remedies gets approval under the PLI scheme

Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products


Venus Remedies H1 net profit rises 315%
News | November 03, 2021

Venus Remedies H1 net profit rises 315%

Venus Remedies has reported consolidated financial results for the period ended September 30, 2021


Budget 2025: Industry welcomes customs duty exemptions on 36 life-saving drugs and medicines
Policy | February 01, 2025

Budget 2025: Industry welcomes customs duty exemptions on 36 life-saving drugs and medicines

The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25


Budget 2025: Industry expects tax incentives and thrust on affordable healthcare
Policy | January 23, 2025

Budget 2025: Industry expects tax incentives and thrust on affordable healthcare

Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials


Industry hails Union Budget 2024-25
Policy | July 23, 2024

Industry hails Union Budget 2024-25

The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable


Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
Policy | February 02, 2023

Budget 2023-24: Industry welcomes focus on medical research and pharma innovation

It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047


Pharma industry seeks fiscal support to drive innovation
News | January 31, 2022

Pharma industry seeks fiscal support to drive innovation

Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India


Fifty-five manufacturers selected for Pharma PLI sector
News | November 27, 2021

Fifty-five manufacturers selected for Pharma PLI sector

The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme